BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
BioGaia Max Drawdown (5Y): 56.24% for Aug. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
August 31, 2024 | 56.24% |
July 31, 2024 | 56.24% |
June 30, 2024 | 56.24% |
May 31, 2024 | 56.24% |
April 30, 2024 | 56.24% |
March 31, 2024 | 56.24% |
February 29, 2024 | 56.24% |
January 31, 2024 | 56.24% |
December 31, 2023 | 56.24% |
November 30, 2023 | 56.24% |
October 31, 2023 | 56.24% |
September 30, 2023 | 56.24% |
August 31, 2023 | 56.24% |
July 31, 2023 | 56.24% |
June 30, 2023 | 56.24% |
May 31, 2023 | 56.24% |
April 30, 2023 | 56.24% |
March 31, 2023 | 56.24% |
February 28, 2023 | 56.24% |
January 31, 2023 | 56.24% |
December 31, 2022 | 56.24% |
November 30, 2022 | 56.24% |
October 31, 2022 | 56.24% |
September 30, 2022 | 56.24% |
August 31, 2022 | 44.57% |
Date | Value |
---|---|
July 31, 2022 | 44.57% |
June 30, 2022 | 44.57% |
May 31, 2022 | 43.41% |
April 30, 2022 | 33.12% |
March 31, 2022 | 33.12% |
February 28, 2022 | 33.12% |
January 31, 2022 | 33.12% |
December 31, 2021 | 33.12% |
November 30, 2021 | 33.12% |
October 31, 2021 | 33.12% |
September 30, 2021 | 33.12% |
August 31, 2021 | 33.12% |
July 31, 2021 | 33.12% |
June 30, 2021 | 33.12% |
May 31, 2021 | 33.12% |
April 30, 2021 | 33.12% |
March 31, 2021 | 33.12% |
February 28, 2021 | 33.12% |
January 31, 2021 | 33.12% |
December 31, 2020 | 33.12% |
November 30, 2020 | 33.12% |
October 31, 2020 | 33.12% |
September 30, 2020 | 33.12% |
August 31, 2020 | 33.12% |
July 31, 2020 | 33.12% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
17.36%
Minimum
Sep 2019
56.24%
Maximum
Sep 2022
41.27%
Average
33.12%
Median
Apr 2020
Max Drawdown (5Y) Benchmarks
Abliva AB | 99.34% |
Karolinska Development AB | -- |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | -- |
BioInvent International AB | 62.75% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 7.744 |
Beta (5Y) | -0.1037 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 41.10% |
Historical Sharpe Ratio (5Y) | 0.1539 |
Historical Sortino (5Y) | 0.2328 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.60% |